Cargando…

Accelerated age-related olfactory decline among type 1 Usher patients

Usher Syndrome (USH) is a rare disease with hearing loss, retinitis pigmentosa and, sometimes, vestibular dysfunction. A phenotype heterogeneity is reported. Recent evidence indicates that USH is likely to belong to an emerging class of sensory ciliopathies. Olfaction has recently been implicated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, João Carlos, Oliveiros, Bárbara, Pereira, Paulo, António, Natália, Hummel, Thomas, Paiva, António, Silva, Eduardo D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916436/
https://www.ncbi.nlm.nih.gov/pubmed/27329700
http://dx.doi.org/10.1038/srep28309
_version_ 1782438830385659904
author Ribeiro, João Carlos
Oliveiros, Bárbara
Pereira, Paulo
António, Natália
Hummel, Thomas
Paiva, António
Silva, Eduardo D.
author_facet Ribeiro, João Carlos
Oliveiros, Bárbara
Pereira, Paulo
António, Natália
Hummel, Thomas
Paiva, António
Silva, Eduardo D.
author_sort Ribeiro, João Carlos
collection PubMed
description Usher Syndrome (USH) is a rare disease with hearing loss, retinitis pigmentosa and, sometimes, vestibular dysfunction. A phenotype heterogeneity is reported. Recent evidence indicates that USH is likely to belong to an emerging class of sensory ciliopathies. Olfaction has recently been implicated in ciliopathies, but the scarce literature about olfaction in USH show conflicting results. We aim to evaluate olfactory impairment as a possible clinical manifestation of USH. Prospective clinical study that included 65 patients with USH and 65 normal age-gender-smoking-habits pair matched subjects. A cross culturally validated version of the Sniffin’ Sticks olfaction test was used. Young patients with USH have significantly better olfactory scores than healthy controls. We observe that USH type 1 have a faster ageing olfactory decrease than what happens in healthy subjects, leading to significantly lower olfactory scores in older USH1 patients. Moreover, USH type 1 patients showed significantly higher olfactory scores than USH type 2, what can help distinguishing them. Olfaction represents an attractive tool for USH type classification and pre diagnostic screening due to the low cost and non-invasive nature of the testing. Olfactory dysfunction should be considered among the spectrum of clinical manifestations of Usher syndrome.
format Online
Article
Text
id pubmed-4916436
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49164362016-06-27 Accelerated age-related olfactory decline among type 1 Usher patients Ribeiro, João Carlos Oliveiros, Bárbara Pereira, Paulo António, Natália Hummel, Thomas Paiva, António Silva, Eduardo D. Sci Rep Article Usher Syndrome (USH) is a rare disease with hearing loss, retinitis pigmentosa and, sometimes, vestibular dysfunction. A phenotype heterogeneity is reported. Recent evidence indicates that USH is likely to belong to an emerging class of sensory ciliopathies. Olfaction has recently been implicated in ciliopathies, but the scarce literature about olfaction in USH show conflicting results. We aim to evaluate olfactory impairment as a possible clinical manifestation of USH. Prospective clinical study that included 65 patients with USH and 65 normal age-gender-smoking-habits pair matched subjects. A cross culturally validated version of the Sniffin’ Sticks olfaction test was used. Young patients with USH have significantly better olfactory scores than healthy controls. We observe that USH type 1 have a faster ageing olfactory decrease than what happens in healthy subjects, leading to significantly lower olfactory scores in older USH1 patients. Moreover, USH type 1 patients showed significantly higher olfactory scores than USH type 2, what can help distinguishing them. Olfaction represents an attractive tool for USH type classification and pre diagnostic screening due to the low cost and non-invasive nature of the testing. Olfactory dysfunction should be considered among the spectrum of clinical manifestations of Usher syndrome. Nature Publishing Group 2016-06-22 /pmc/articles/PMC4916436/ /pubmed/27329700 http://dx.doi.org/10.1038/srep28309 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Ribeiro, João Carlos
Oliveiros, Bárbara
Pereira, Paulo
António, Natália
Hummel, Thomas
Paiva, António
Silva, Eduardo D.
Accelerated age-related olfactory decline among type 1 Usher patients
title Accelerated age-related olfactory decline among type 1 Usher patients
title_full Accelerated age-related olfactory decline among type 1 Usher patients
title_fullStr Accelerated age-related olfactory decline among type 1 Usher patients
title_full_unstemmed Accelerated age-related olfactory decline among type 1 Usher patients
title_short Accelerated age-related olfactory decline among type 1 Usher patients
title_sort accelerated age-related olfactory decline among type 1 usher patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916436/
https://www.ncbi.nlm.nih.gov/pubmed/27329700
http://dx.doi.org/10.1038/srep28309
work_keys_str_mv AT ribeirojoaocarlos acceleratedagerelatedolfactorydeclineamongtype1usherpatients
AT oliveirosbarbara acceleratedagerelatedolfactorydeclineamongtype1usherpatients
AT pereirapaulo acceleratedagerelatedolfactorydeclineamongtype1usherpatients
AT antonionatalia acceleratedagerelatedolfactorydeclineamongtype1usherpatients
AT hummelthomas acceleratedagerelatedolfactorydeclineamongtype1usherpatients
AT paivaantonio acceleratedagerelatedolfactorydeclineamongtype1usherpatients
AT silvaeduardod acceleratedagerelatedolfactorydeclineamongtype1usherpatients